X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.contractpharma.com/contents/view_breaking-news/2024-04-09/askbio-names-dr-mansuo-shannon-as-chief-scientific-officer/
https://www.business-standard.com/markets/capital-market-news/dr-reddy-s-labs-partners-with-bayer-for-second-brand-of-vericiguat-for-india-market-124040600101_1.html
https://www.fiercepharma.com/pharma/big-pharma-ceos-gather-beijing-continued-interest-china-policy-advice-local-drug-industry
https://www.biospectrumasia.com/news/105/23967/bayer-and-thermo-fisher-collaborate-to-increase-patient-access-to-precision-cancer-medicines.html
https://www.jnj.com/new-voyager-pad-analyses-reinforce-benefit-of-xarelto-rivaroxaban-plus-aspirin-across-high-risk-and-complex-patient-populations-with-peripheral-artery-disease-pad
https://www.prnewswire.com/news-releases/bluerocks-phase-i-study-with-bemdaneprocel-in-patients-with-parkinsons-disease-meets-primary-endpoint-301910863.html
https://www.prnewswire.com/news-releases/novel-combination-of-oral-ketamine-and-aspirin-is-safe-form-of-pain-medication-after-total-knee-replacement-surgery-301902136.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/now-you-will-need-a-prescription-for-buying-aspirin-ibrufin-diclofinac-in-delhi-read-why/articleshow/102003935.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://recalls-rappels.canada.ca/en/alert-recall/jamp-asa-ec-product-quality
https://www.prnewswire.com/news-releases/new-voyager-pad-analysis-confirms-consistent-benefit-of-xarelto-rivaroxaban-plus-aspirin-following-lower-extremity-revascularization-ler-301762498.html
https://www.fiercepharma.com/marketing/plx-pharma-strikes-new-collab-baseball-legend-john-smoltz-take-its-pain-drug-vazalore
https://www.escardio.org/The-ESC/Press-Office/Press-releases/COVID-19-patients-in-the-community-do-not-benefit-from-colchicine-or-aspirin
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-27-2022-1659339221.pdf
https://www.prnewswire.com/news-releases/new-data-from-two-large-studies-reinforce-effectiveness-of-dual-pathway-inhibition-dpi-with-xarelto-rivaroxaban-plus-aspirin-in-patients-with-coronary-artery-disease-cad-andor-peripheral-artery-disease-pad-301552796.html
https://www.prnewswire.com/news-releases/data-from-new-voyager-pad-analyses-at-acc22-reinforce-benefit-of-xarelto-rivaroxaban-plus-aspirin-in-patients-with-peripheral-artery-disease-pad-and-various-co-morbid-conditions-301515529.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211695
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-26-2022-1643358623.pdf
https://www.fiercebiotech.com/biotech/jpm-2022-bayer-s-research-head-looks-to-reinvent-r-d-as-pharma-innovates-biotech
https://newsroom.heart.org/news/long-term-low-dose-aspirin-did-not-affect-risk-of-dementia-in-adults-with-type-2-diabetes
https://www.globenewswire.com/news-release/2021/11/04/2327725/37097/en/PLx-Pharma-Inc-Announces-New-Scientific-Data-Available-Evaluating-the-Pharmacologic-Profile-of-FDA-Approved-VAZALORE-81-mg-Liquid-Filled-Aspirin-Capsules.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205230
https://www.globenewswire.com/news-release/2021/10/14/2314570/37097/en/PLx-Pharma-Inc-Issues-Statement-on-Recent-USPTF-Recommendations-on-Aspirin-Therapy-for-Primary-Prevention-of-Cardiovascular-Disease-PLx-s-VAZALORE-Specifically-Indicated-for-Second.html
https://www.biospace.com/article/plx-pharma-inc-issues-statement-on-recent-usptf-recommendations-on-aspirin-therapy-for-primary-prevention-of-cardiovascular-disease-plx-s-vazalore/?s=71
https://www.globenewswire.com/news-release/2021/10/13/2313079/0/en/Hyloris-Acquires-Breakthrough-Patented-Technology-to-Develop-and-Market-Aspirin-IV-in-the-U-S-in-Acute-Coronary-Syndrome.html
https://www.clinicaltrialsarena.com/news/janssen-xarelto-blood-clots/
http://www.pharmafile.com/news/585675/aspirin-trialled-potential-treatment-aggressive-form-breast-cancer
https://www.irishtimes.com/news/health/aspirin-could-cut-mortality-risk-in-cancer-patients-by-20-1.4609957
https://www.seqens.com/en/white-paper-on-aspirin-1st-result-of-the-technology-cooperation-between-seqens-and-rondol-announced-in-march/
https://www.reuters.com/business/healthcare-pharmaceuticals/aspirin-does-not-improve-survival-covid-19-patients-uk-study-2021-06-08/
https://www.newswire.ca/news-releases/labelling-update-regarding-the-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-beyond-20-weeks-of-pregnancy-and-risk-of-kidney-damage-to-unborn-babies-866562162.html
https://www.reuters.com/business/healthcare-pharmaceuticals/aspirin-does-not-improve-survival-covid-19-patients-uk-study-2021-06-08/
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01063-1/fulltext
https://www.cnn.com/2021/03/18/health/aspirin-coronavirus-icu-wellness/index.html
https://endpts.com/seqens-majority-owner-looking-to-sell-api-maker-amid-record-high-run-in-healthcare-valuations-report/
https://www.nih.gov/news-events/news-releases/low-dose-aspirin-may-improve-pregnancy-chances-women-one-or-two-prior-miscarriages
https://www.sciencedaily.com/releases/2021/01/210121131758.htm#:~:text=when%20they%20start-,Study%20finds%20that%20daily%20aspirin%20use%20does%20not%20reduce%20risk,taking%20it%20after%20age%2070&text=Summary%3A,aspirin%20regularly%20after%20age%2070.
https://newsroom.heart.org/news/new-study-confirms-combo-pill-alone-and-with-aspirin-lowers-heart-disease-risk
https://www.recoverytrial.net/news/aspirin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-the-recovery-trial
https://www.sciencedaily.com/releases/2020/10/201030111842.htm#:~:text=2-,Aspirin%20use%20best%20for%20those%20with,calcium%2C%20low%20risk%20of%20bleeding&text=Summary%3A,from%20its%20use%2C%20research%20suggests.
https://www.europeanpharmaceuticalreview.com/news/131047/aspirin-could-protect-patients-from-severe-covid-19-complications/
https://www.europeanpharmaceuticalreview.com/news/131047/aspirin-could-protect-patients-from-severe-covid-19-complications/
Market Place
Share 
